Lissencephaly: Difference between revisions

mNo edit summary
("Clinical Presentation" information is added.)
Line 4: Line 4:


<div class="noeditbox">
<div class="noeditbox">
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (07/05/2023)
This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (10/05/2023)
</div>
</div>


Line 46: Line 46:


== Clinical Presentation  ==
== Clinical Presentation  ==
Clinical symptoms/findings of lissencephaly can be various including:
* Neurodevelopmental delay
* Intellectual disability
* Drug-resistant epilepsy
* Spastic quadriparesis
* Hypotonia
* Hypertonia
* Facial dysmorphism: Usually MDS-related high forehead, small jaw, short upturned nose, protruberant upper lip and bitemporal narrowing. <ref>Dobyns WB, Curry CJ, Hoyme HE, Turlington L, Ledbetter DH. [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1682996/ Clinical and molecular diagnosis of Miller-Dieker syndrome.] American journal of human genetics. 1991 Mar;48(3):584.</ref><ref>Cardoso C, Leventer RJ, Ward HL, Toyo-Oka K, Chung J, Gross A, Martin CL, Allanson J, Pilz DT, Olney AH, Mutchinick OM. [https://www.sciencedirect.com/science/article/pii/S0002929707606132 Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13. 3.] The American Journal of Human Genetics. 2003 Apr 1;72(4):918-30.</ref>
* Microcephaly
* Macrocephaly
* Low weight for age
== Diagnostic Procedures  ==  
== Diagnostic Procedures  ==  



Revision as of 17:43, 10 May 2023

This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (10/05/2023)


Introduction[edit | edit source]

Lissencephaly (LIS) is a spectrum that includes various brain malformations. [1] Its prevalence is estimated at 11.7 to 40 per million births. [2]

It is derived from the combination of two Greek words meaning soft ("lissos") and brain ("enkephalos"). [2] This smooth appearance of the brain, which can be observed in MRI imaging, is associated with malformations of cortical development such as agyria (absence of gyrus), pachygyria (extremely wide gyrus), and subcortical band heterotopia (double cortex). [1][3]

Lissencephaly is generally divided into two subtypes: type 1 (classic LIS) and type 2 (cobblestone LIS). [4]

Type 1 can present in different forms such as isolated LIS, Miller-Dieker Syndrome (MDS), Norman-Roberts syndrome, and X-linked LIS with ambiguous genitalia (XLAG). [5][6]

Type 2 represents the severe end of a spectrum and can present in three syndromes: Walker-Warburg syndrome (WWS), muscle eye-brain (MEB) disease, and Fukuyama congenital muscular dystrophy (FCMD). [7][8][6]

Clinically Relevant Anatomy[edit | edit source]

The cerebral cortex is the outermost part of the brain surrounded by meninges. [9] It contains about 16 billion neurons, making up more than eighty per cent of the total weight of the brain. [10]

The development of the cerebral cortex, which is anatomically composed of the neocortex (or isocortex) and allocortex, [11] begins in the uterus at the rostral (anterior) portion of the neural tube. [12] With the proliferation of neurons in the forebrain, the 6-layer structure, which is the initial state of the neocortex, is formed. [13][11]

Later, as the volume of the brain grows, folding occurs, forming the gyrus and sulcus of the brain. [14] This process, called gyrification, is an adaptation of the brain to fit into the cranium, [4] starts in the 2nd trimester of gestation, [12] peaks in early adolescence, stabilise in adulthood and regresses with ageing. [15]

Gyrification is also important for the functional organization of the brain. [4] Prominent sulci such as Sylvian, central, parieto-occipital and calcarine divide the brain roughly into 4 lobes (frontal, parietal, temporal, occipital) each of which is specialized functions. [9][16]

As in lissencephaly, disruptions that occur in the gyrification process cause changes in the structure and thus function of the brain, leading to intellectual, and motor disability and intractable epilepsy. [12][4]

Pathological Process[edit | edit source]

Lissencephaly is caused by genetic (mutations especially in LIS1 (PAFAH1B1) gene for classic LIS, [17] doublecortin (DCX) gene for SBH [6] and TUBA1A gene for microcephaly [18]) or non-genetic factors (viral infections, [6] [19] hypoxia, [6] preterm birth [20]).

Pathological processes caused by genetic mutations can be summarized as follows;

Primitive neurons (neuroblasts) generated from the stem cells in the neural tube should migrate through the entire cortical thickness and stop precisely near the cortical surface, but instead, they fail to migrate and position properly. [21][4]

In type 1 LIS they accumulate below the preplate in only four layers, thus causing thickened cortex with reduced folding (pachygyria or agyria). [22][2]

Their accumulation in the cortical white matter just below the cortical grey matter and forming a thick grey layer called SBH. Reduction in the size of the cerebral cortex and some cases also microgyria accompany this. [23][24][25]

In type 2 LIS because of the impaired cortical basement membrane, they over-migrate into the subarachnoid space, causing a bumpy appearance as cobblestones on the cortical surface. [26][27]

Clinical Presentation[edit | edit source]

Clinical symptoms/findings of lissencephaly can be various including:

  • Neurodevelopmental delay
  • Intellectual disability
  • Drug-resistant epilepsy
  • Spastic quadriparesis
  • Hypotonia
  • Hypertonia
  • Facial dysmorphism: Usually MDS-related high forehead, small jaw, short upturned nose, protruberant upper lip and bitemporal narrowing. [28][29]
  • Microcephaly
  • Macrocephaly
  • Low weight for age

Diagnostic Procedures[edit | edit source]

Outcome Measures[edit | edit source]

Management[edit | edit source]

Differential Diagnosis[edit | edit source]

Resources[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 Koenig M, Dobyns WB, Di Donato N. Lissencephaly: Update on diagnostics and clinical management. European Journal of Paediatric Neurology. 2021 Nov 1;35:147-52.
  2. 2.0 2.1 2.2 Fry AE, Cushion TD, Pilz DT. The genetics of lissencephaly. InAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics 2014 Jun (Vol. 166, No. 2, pp. 198-210).
  3. Malinger G, Kidron D, Schreiber L, Ben‐Sira L, Hoffmann C, Lev D, Lerman‐Sagie T. Prenatal diagnosis of malformations of cortical development by dedicated neurosonography. Ultrasound in Obstetrics and Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2007 Feb;29(2):178-91.
  4. 4.0 4.1 4.2 4.3 4.4 Fernández V, Llinares‐Benadero C, Borrell V. Cerebral cortex expansion and folding: what have we learned?. The EMBO journal. 2016 May 17;35(10):1021-44.
  5. Herrera JF, Ramírez RG, Zárate MD. Lisencefalia tipo I: síndrome de Miller-Dieker. Informe de un caso. Revista Mexicana de Pediatría. 1999;66(4):157-60.
  6. 6.0 6.1 6.2 6.3 6.4 Juric-Sekhar G, Hevner RF. Malformations of cerebral cortex development: molecules and mechanisms. Annual Review of Pathology: Mechanisms of Disease. 2019 Jan 24;14:293-318.
  7. Shenoy AM, Markowitz JA, Bonnemann CG, Krishnamoorthy K, Bossler AD, Tseng BS. Muscle-eye-brain disease. Journal of clinical neuromuscular disease. 2010 Mar;11(3):124.
  8. Angelini C, Angelini C. Fukuyama congenital muscular dystrophy: walker-warburg syndrome. Springer International Publishing; 2018.
  9. 9.0 9.1 Javed K, Reddy V, Lui F. Neuroanatomy, cerebral cortex [Internet]. Treasure Island.
  10. Azevedo FA, Carvalho LR, Grinberg LT, Farfel JM, Ferretti RE, Leite RE, Filho WJ, Lent R, Herculano‐Houzel S. Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled‐up primate brain. Journal of Comparative Neurology. 2009 Apr 10;513(5):532-41.
  11. 11.0 11.1 Cadwell CR, Bhaduri A, Mostajo-Radji MA, Keefe MG, Nowakowski TJ. Development and arealization of the cerebral cortex. Neuron. 2019 Sep 25;103(6):980-1004.
  12. 12.0 12.1 12.2 Quezada S, Castillo‐Melendez M, Walker DW, Tolcos M. Development of the cerebral cortex and the effect of the intrauterine environment. The Journal of physiology. 2018 Dec;596(23):5665-74.
  13. Agirman G, Broix L, Nguyen L. Cerebral cortex development: an outside‐in perspective. FEBS letters. 2017 Dec;591(24):3978-92.
  14. Welker W. Why does cerebral cortex fissure and fold? A review of determinants of gyri and sulci. Cerebral Cortex: comparative structure and evolution of Cerebral Cortex, Part II. 1990:3-136.
  15. Raznahan A, Shaw P, Lalonde F, Stockman M, Wallace GL, Greenstein D, Clasen L, Gogtay N, Giedd JN. How does your cortex grow?. Journal of Neuroscience. 2011 May 11;31(19):7174-7.
  16. Stiles J, Jernigan TL. The basics of brain development. Neuropsychology review. 2010 Dec;20(4):327-48.
  17. Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, Dobyns WB, Caskey CT, Ledbetter DH. Isolation of a Miller–Dicker lissencephaly gene containing G protein β-subunit-like repeats. Nature. 1993 Aug 19;364(6439):717-21.
  18. Chang BS. Tubulinopathies and their brain malformation syndromes: every TUB on its own bottom: the phenotypic Spectrum of Tubulinopathies. Epilepsy Currents. 2015 Mar;15(2):65-7.
  19. Lapo-Córdova NS, Ruiz-García M, Hernández-Antúnez BG. Lissencephaly: Clinical and neuroimaging features in children. Revista mexicana de neurociencia. 2021 Aug;22(4):134-40.
  20. Brown WR. Association of preterm birth with brain malformations. Pediatric research. 2009 Jun;65(6):642-6.
  21. Wynshaw-Boris A, Pramparo T, Youn YH, Hirotsune S. Lissencephaly: mechanistic insights from animal models and potential therapeutic strategies. InSeminars in cell & developmental biology 2010 Oct 1 (Vol. 21, No. 8, pp. 823-830). Academic Press.
  22. Golden JA, Harding BN. Developmental neuropathology. (No Title). 2004.
  23. Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. A developmental and genetic classification for malformations of cortical development: update 2012. Brain. 2012 May 1;135(5):1348-69.
  24. Barkovich AJ, Kuzniecky RI, Dobyns WB. Radiologic classification of malformations of cortical development. Current opinion in neurology. 2001 Apr 1;14(2):145-9.
  25. Ross ME, Walsh CA. Human brain malformations and their lessons for neuronal migration. Annual review of neuroscience. 2001 Mar;24(1):1041-70.
  26. Barkovich AJ, Dobyns WB, Guerrini R. Malformations of cortical development and epilepsy. Cold Spring Harbor perspectives in medicine. 2015 May 1;5(5):a022392.
  27. Van Reeuwijk J, Brunner HG, Van Bokhoven H. Glyc‐O‐genetics of Walker–Warburg syndrome. Clinical genetics. 2005 Apr;67(4):281-9.
  28. Dobyns WB, Curry CJ, Hoyme HE, Turlington L, Ledbetter DH. Clinical and molecular diagnosis of Miller-Dieker syndrome. American journal of human genetics. 1991 Mar;48(3):584.
  29. Cardoso C, Leventer RJ, Ward HL, Toyo-Oka K, Chung J, Gross A, Martin CL, Allanson J, Pilz DT, Olney AH, Mutchinick OM. Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13. 3. The American Journal of Human Genetics. 2003 Apr 1;72(4):918-30.